GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Current Accrued Expense

Cantourage Group SE (XTER:HIGH) Current Accrued Expense : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Current Accrued Expense?

Cantourage Group SE's Current Accrued Expense for the quarter that ended in Jun. 2023 was €0.00 Mil.


Cantourage Group SE Current Accrued Expense Historical Data

The historical data trend for Cantourage Group SE's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Current Accrued Expense Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Current Accrued Expense
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Current Accrued Expense Get a 7-Day Free Trial - - - - -

Cantourage Group SE Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Cantourage Group SE Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines